1. Moving toward a process-oriented perspective in the personalized treatment of depression

   • Johannes Kopf-Beck
   • Julia Fietz

   Editorial Open access 05 March 2021 Pages: 413 - 415

2. Esketamine: a glimmer of hope in treatment-resistant depression

   • Upinder Kaur
   • Bhairav Kumar Pathak
   • Sankha Shubhra Chakrabarti

   Invited Review 19 November 2019 Pages: 417 - 429

   

3. Working memory associated with anti-suicidal ideation effect of repeated-dose intravenous ketamine in depressed patients

   • Xiaoyu Chen
   • Mingqia Wang
   • Bin Zhang

   Original Paper 01 January 2021 Pages: 431 - 438

   

4. Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling

   • Youge Qu
   • Jiajing Shan
   • Kenji Hashimoto

   Original Paper 12 November 2020 Pages: 439 - 446

   

5. Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine

   • Kai Zhang
   • Akemi Sakamoto
   • Kenji Hashimoto

   Original Paper Open access 24 December 2019 Pages: 447 - 456

   

6. Empirical ratio of the combined use of S-ketamine and propofol in electroconvulsive therapy and its impact on seizure quality

   • Alexander Sartorius
   • Juliane Beuschlein
   • Christoph Janke

   Original Paper Open access 22 July 2020 Pages: 457 - 463

   

7. Similar clinical improvement of depression using 0.5-ms and 1-ms pulse widths in bilateral electroconvulsive therapy

   • Aida de Arriba-Arnau
   • Virginia Soria
   • Mikel Urretavizcaya

   Original Paper 13 December 2019 Pages: 465 - 473

8. Inflammatory cytokines derived from peripheral blood contribute to the modified electroconvulsive therapy-induced cognitive deficits in major depressive disorder

   • Haihua Tian
   • Guangxue Li
   • Shugui Gao

   Original Paper 02 May 2020 Pages: 475 - 485

   

9. Efficacy of anticonvulsant ethosuximide for major depressive disorder: a randomized, placebo-control clinical trial

   • Kai Zhang
   • Gang Jia
   • Guoqiang Wang

   Original Paper 01 February 2020 Pages: 487 - 493

   

10. Cognitive Behavioral Analysis System of Psychotherapy for inpatients with persistent depressive disorder: a naturalistic trial on a general acute psychiatric unit

    • Anne Guhn
    • Stephan Köhler
    • Philipp Sterzer

    Original Paper 12 July 2019 Pages: 495 - 505

    

11. Inflammatory processes linked to major depression and schizophrenic disorders and the effects of polypharmacy in psychiatry: evidence from a longitudinal study of 279 patients under therapy

    • H. H. Stassen
    • S. Bachmann
    • E. Seifritz

    Original Paper Open access 21 July 2020 Pages: 507 - 520

    

12. Melancholic features (DSM-IV) predict but do not moderate response to antidepressants in major depression: an individual participant data meta-analysis of 1219 patients

    • Hissei Imai
    • Hisashi Noma
    • Toshi A. Furukawa

    Original Paper 26 July 2020 Pages: 521 - 526

13. Fatigue and brain arousal in patients with major depressive disorder

    • Galina Surova
    • Christine Ulke
    • Ulrich Hegerl

    Original Paper Open access 04 December 2020 Pages: 527 - 536

    

14. ACC Glu/GABA ratio is decreased in euthymic bipolar disorder I patients: possible in vivo neurometabolite explanation for mood stabilization

    • Estêvão Scotti-Muzzi
    • Thais Chile
    • Márcio Gerhardt Soeiro-de-Souza

    Original Paper 28 January 2020 Pages: 537 - 547

    

15. E-mental health applications for depression: an evidence-based ethical analysis

    • Giovanni Rubeis

    Original Paper 01 January 2020 Pages: 549 - 555

16. Differential neural processing of unpleasant sensory stimulation in patients with major depression

    • Kathrin Malejko
    • Rebecca C. Brown
    • Birgit Abler

    Original Paper Open access 11 April 2020 Pages: 557 - 565

    

17. Reduced ribosomal DNA transcription in the prefrontal cortex of suicide victims: consistence of new molecular RT-qPCR findings with previous morphometric data from AgNOR-stained pyramidal neurons

    • Marta Krzyżanowska
    • Krzysztof Rębała
    • Tomasz Gos

    Original Paper Open access 26 January 2021 Pages: 567 - 576

    

18. Intravenous arketamine for treatment-resistant depression: open-label pilot study

    • Gustavo C. Leal
    • Igor D. Bandeira
    • Lucas C. Quarantini

    Short Communication 20 February 2020 Pages: 577 - 582

    

19. Neural rhythm in the retrosplenial cortex during ketamine-induced dissociation

    • Kenji Hashimoto

    Letter to the Editor 12 January 2021 Pages: 583 - 585

20. AgNOR parameters of dorsal raphe nucleus neurons as a potential diagnostic tool which could aid the differentiation between suicidal and non-suicidal death

    • Marta Krzyżanowska
    • Johann Steiner
    • Tomasz Gos

    Letter to the Editor 07 April 2020 Pages: 587 - 589